Fred P. Lampropoulos has been leading Merit Medical Systems since December 2015 as both the CEO and President. Under his leadership, the company has not only focused on critical areas like strategic business development and product innovation but has also...

Current Market Cap

$6.08B

Number of Employees

6.95K

Total Compensation

2019 - 2023

Trending up by 114.81% last year
Showing total compensation for the last 2019 - 2023

Stock

Up by 0.00% last year

Salary

Up by 5.00% last year

Bonus

Up by 35.30% last year

Other

Up by 0.00% last year

Year

2023

Total Compensation

$6.01M

Salary

$1.89M

Board Justification

The compensation philosophy is to align the interests of management and shareholders for the purpose of maximizing shareholder value, while considering the interests of other significant stakeholders such as employees, patients, customers, business partners and the communities in which we operate.

Bonus

$1.34M

Board Justification

Based on the Company’s achievement of goals established by the Compensation Committee, the Compensation Committee determined to award and pay the annual cash bonus at 118.12% of the target payment amount for 2023.

Other

$8.70K

Board Justification

Includes matching contributions made by the Company for the benefit of Mr. Lampropoulos to the Company’s 401(k) Plan.

Restricted Stock

$2.77M(18.96K RSU)

Board Justification

Represents the number of shares of stock that vested in 2023 under the performance stock units (PSUs) granted in prior years, based on the achievement of performance metrics.

Performance Metrics

The performance metrics for determining the compensation of the CEO include total shareholder return, net sales, non-GAAP operating margin, non-GAAP earnings per share, and adjusted free cash flow.

SEC Filing

From April 2, 2024